Wacker Chemie Shareholders Face Dividend Suspension

Wacker Chemie AG will pay no dividend for 2025 after an €805M net loss. The company is cutting 1,500 jobs and raising prices to save €300M+ annually.

Investors in Wacker Chemie AG are set to receive disappointing news at the Annual General Meeting scheduled for May 6, 2026. The company's management will propose distributing no dividend for the 2025 fiscal year. Instead, the entire retained earnings of approximately €814.75 million are to be carried forward to new accounts—a clear indication of the severe challenges the chemical group has recently endured.

A Year Marked by Significant Losses and Industry-Wide Pressures

The driver behind this decision is a substantial net loss of €805 million for 2025. This financial result was primarily driven by reduced capacity utilization across its plants, weaker sales volumes, sustained price pressure, and adverse currency translation effects. These company-specific issues were compounded by structural headwinds buffeting the entire chemical sector, including tepid demand, persistently high energy costs, and significant overcapacity.

In response, Wacker Chemie is aggressively advancing its comprehensive "PACE" restructuring initiative. The program targets annual cost savings exceeding €300 million and includes plans to reduce its global workforce by around 1,500 positions by the end of 2027. Furthermore, in a move to offset rising input costs—notably for platinum—the company began implementing price increases of up to 25% on selected silicone products in February 2026.

Analysts Identify a Potential Turning Point

Looking ahead, management has provided guidance for 2026, forecasting a low single-digit percentage increase in sales. Adjusted EBITDA is projected to land between €550 million and €700 million. The company explicitly notes that this outlook does not factor in any potential economic repercussions from ongoing geopolitical tensions in the Gulf region.

Despite the current difficulties, some market observers see a path to recovery. Analysts at private bank Berenberg have assigned a "Buy" rating to Wacker Chemie shares, accompanied by a price target of €96. They interpret the latest annual figures and quarterly forecast as initial signals that the cost-cutting measures may be starting to take hold. With the stock currently trading at €70.80—approximately 15% below its 52-week high of €83.40—this target suggests considerable upside potential. A Relative Strength Index (RSI) reading of just under 25 also points to a technically oversold condition.

The upcoming shareholder meeting on May 6 will likely serve as a key barometer of investor sentiment. However, the true efficacy of the PACE restructuring plan and the success of recent price hikes in stabilizing margins will become clearer with the release of subsequent quarterly financial reports.